Panobinostat (Farydak) for multiple myeloma.
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D056572:Histone Deacetylase Inhibitors / Q000627:therapeutic use*; D006801:Humans; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D007211:Indoles / Q000627:therapeutic use*; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000378:metabolism; D000077767:Panobinostat; D016032:Randomized Controlled Trials as Topic / Q000379:methods
D000970:Antineoplastic Agents; D056572:Histone Deacetylase Inhibitors; D006877:Hydroxamic Acids; D007211:Indoles; D000077767:Panobinostat